Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Peng, Yingpeng
ZDWY.TJBZLK.003, NCT06220552: The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma	Recruiting	2	20	RoW	Sintilimab, Low-dose Radiotherapy	Fifth Affiliated Hospital, Sun Yat-Sen University	Recurrent Glioblastoma	12/27	12/27
NCT05854823: The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR	Recruiting	2	23	RoW	dose-reduced radiotherapy	Fifth Affiliated Hospital, Sun Yat-Sen University	Head and Neck Squamous Cell Carcinoma	04/27	04/27